Onset Ventures

News, insights, analysis and data

← Back to Onset Ventures profile

Onset Ventures related stories

All articles and analysis

  • Investors cash in on payment companies
    Brad Meikle- 10 August 2009

    More than a dozen startups have rung up an excess of $200M from VCs

  • Cashing In On Payments
    Staff Writer- 1 August 2009

    VCs have invested more than $200M in over a dozen payment-related startups this year

  • Week in deals, July 20, 2009
    Brad Meikle- 20 July 2009

    Summary of North American tech companies and other businesses that raised venture-related financing in the past week

  • Exit watch, week of July 20, 2009
    Brad Meikle- 20 July 2009

    News briefs about VC-backed companies getting acquired in the past week

  • Vindicia Raises $7.5 Million
    VCJ Staff- 14 July 2009

    Vindicia, a Redwood City, Calif.-based provider of on-demand payment manages services, has raised $7.5 million in Series D funding. Onset Ventures led the round, and was joined by return backers Bertelsmann Digital Media Investments, DCM and Leader Ventures. The company has now raised over $21 million in total VC funding.

  • peHUB Wire: Tuesday, July 14, 2009
    Brad Meikle- 14 July 2009

    Random Ramblings

  • peHUB Wire: Tuesday, July 14, 2009
    Brad Meikle- 14 July 2009

    Random Ramblings

  • Exit Watch, week of July 13, 2009
    Brad Meikle- 13 July 2009

    VCs get some cash back from failed Pegasus Biologics, August- and MDV-backed Done Right goes to Tree.com

  • Week in deals, July 13, 2009
    Brad Meikle- 13 July 2009

    Summary of tech companies and other businesses that raised financing in the past week

  • Synovis Buys Pegasus Biologics
    VCJ Staff- 9 July 2009

    Synovis Life Technologies Inc. (Nasdaq: SYNO) has agreed to acquire the assets of Pegasus Biologics Inc., an Irvine, Calif.-based developer of bioimplants for soft-tissue repair and wound care for diabetic ulcers. The deal is valued at $12.1 million in cash. Pegasus ceased operations earlier this year, after being unable to secure new financing. It had previously raised $32 million over three funding rounds, from Onset Ventures, Affinity Capital Management, Three Arch Partners and Frazier Healthcare Ventures.